TABLE 5.
Postchallenge neutralization titers
Sample no.a | Immunizedb | Time (wk)c | 90% PRNT | GMT |
---|---|---|---|---|
YFV/dengue-2 virus | ||||
2.11 | − | 3 | 1:160 | 1:60d,e |
2.12 | − | 3 | 1:80 | |
2.13 | − | 3 | 1:80 | |
2.14 | − | 3 | 1:20 | |
2.15 | − | 3 | 1:80 | |
2.16 | − | 3 | 1:160 | |
2.17 | − | 3 | 1:40 | |
2.18 | + | 3 | 1:80 | 1:134d,f |
2.19 | + | 3 | 1:320 | |
2.20 | + | 3 | 1:80 | |
2.21 | + | 3 | 1:160 | |
Mock | <1:20 | |||
Positive | 1:4,000 | |||
YFV/dengue-4 virus | ||||
4.13 | − | 3 | 1:160 | 1:101e,g |
4.14 | − | 3 | 1:160 | |
4.15 | − | 3 | 1:40 | |
4.16 | + | 3 | 1:320 | 1:501f,g |
4.17 | + | 3 | 1:320 | |
4.18 | + | 3 | 1:1280 | |
4.19 | + | 3 | 1:320 | |
4.20 | + | 3 | 1:160 | |
Mock | <1:20 | |||
Positive | 1:8,000 |
Mock and positive are described in Materials and Methods.
−, not immunized; +, immunized.
Weeks postchallenge.
P < 0.05.
P < 0.05.
P < 0.05.
P < 0.05.